eFFECTOR Therapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$1.43M N/A	$3.55M 148.46%	$0 -100%	Avg: $2.2M Low: $2.2M High: $2.2M avg. 0%	Avg: $0 Low: $0 High: $0 avg. -100%	Avg: $51.3M Low: $51.3M High: $51.3M avg. 0%
Net Income % change YoY	$15.79M N/A	$-12.92M -181.82%	$-35.81M -177.02%	Avg: $-37.1M Low: $-4.92M High: $-4.92M avg. -3.59%	Avg: $-45.92M Low: $-45.92M High: $-45.92M avg. -23.78%	Avg: $-38.27M Low: $-38.27M High: $-38.27M avg. 16.66%
EBITDA % change YoY	$-31.89M N/A	$-32.40M -1.58%	$-33.73M -4.10%	Avg: $168.19K Low: $168.19K High: $168.19K avg. 100.49%	Avg: $0 Low: $0 High: $0 avg. -100%	Avg: $3.92M Low: $3.92M High: $3.92M avg. 0%
EPS % change YoY	$9.78 N/A	-$7.85 -180.26%	-$16.37 -108.53%	Avg: -$2.25 Low: -$2.25 High: -$2.25 avg. 86.25%	Avg: -$21 Low: -$21 High: -$21 avg. -833.33%	Avg: -$17.5 Low: -$17.5 High: -$17.5 avg. 16.66%
Operating Expenses % change YoY	$31.89M N/A	$32.40M 1.58%	$33.84M 4.44%	Avg: $6.60M Low: $6.60M High: $6.60M avg. -80.48%	Avg: $0 Low: $0 High: $0 avg. -100%	Avg: $154.02M Low: $154.02M High: $154.02M avg. 0%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -3.57% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -4.92M, average is -37.1M and high is -4.92M.

We have gathered data from 1 analysts. Their low revenue estimate is $2.2M, average is $2.2M and high is $2.2M.

Wall Street analysts forecast annual average earnings growth of -243.47% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.25, average is -$2.25 and high is $-2.25.